A Self-Help Method for Nightmares

NCT ID: NCT00513045

Last Updated: 2008-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

399 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-04-30

Study Completion Date

2008-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to validate a newly designed self-help treatment for nightmares. This self-help treatment is based on Imagery Rehearsal Therapy. This treatment will be validated in comparison to an exposure treatment a diary condition and a waiting list condition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nightmares

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Nightmares treatment self-help

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IRT

Intervention based on Imagery Rehearsal Therapy

Group Type EXPERIMENTAL

IRT

Intervention Type BEHAVIORAL

Cognitive behavior intervention

Exposure

Treatment based on exposure

Group Type ACTIVE_COMPARATOR

Exposure

Intervention Type BEHAVIORAL

Exposure intervention

Nightmare diary

Recording nightmares in a diary

Group Type NO_INTERVENTION

No interventions assigned to this group

Waiting list

Waiting list

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IRT

Cognitive behavior intervention

Intervention Type BEHAVIORAL

Exposure

Exposure intervention

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Suffering from Nightmares
* Access to internet
* A valid e-mail address
* Be able to understand Dutch

Exclusion Criteria

* Severe posttraumatic complaints
* Severe depression
* High anxiety ratings
* In therapy for post traumatic stress disorder
* Being suicidal
* Schizophrenic or having a psychosis episode
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fonds Psychische Gezondheid

OTHER

Sponsor Role collaborator

Utrecht University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Utrecht University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jan Van den Bout, Prof. dr.

Role: STUDY_DIRECTOR

Utrecht University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Utrecht University

Utrecht, Utrecht, Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FPG20066126

Identifier Type: -

Identifier Source: org_study_id